Clinical Trials Directory

Trials / Completed

CompletedNCT05391958

Pharmacodynamics of Injection of Cisatracurium Base on Lean Body Mass Pattern to Maintain Deep Neuromuscular Blockade in Obese Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
The First Hospital of Qinhuangdao · Other Government
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

To observe the pharmacodynamics of intravenous injection of cisatracurium to maintain deep neuromuscular blockade in obese patients with lean body mass in laparoscopic colorectal surgery

Detailed description

According to the random number table method, one hundred and twenty patients who underwent elective laparoscopic colorectal surgery were divided into four groups (n=30): Normal weight patients according to lean body weight group(NL group), normal weight patients according to real weight group (NR group), obese patients according to lean body weight group(OL group), and obese patients according to real weight group(OR group).Intraoperative deep neuromuscular blockade (PTC≤2)was maintained in all four groups.The dosage of cisatracurium, the number of injections,time to effect,time to recovery from TOFr,time to recover TOFr(train-of-four rate) to 0.7 and 0.9,and time to stay in PCAU were recorded.The surgeon's satisfaction with the operative field and the average intraoperative pneumoperitoneum pressure were recorded at the time of pneumoperitoneum establishment,1 hour and 2 hours after pneumoperitoneum establishment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALbase on Lean Body Mass PatternPTC(post-tetanic count) was measured every 6min during the operation, and single injection of 0.05 (1ED95) mg/kg cisatracurium that was calculated based on lean body weight mass pattern once when PTC \> 2.
BEHAVIORALbase on Actual Body WeightPTC was measured every 6min during the operation, and single injection of 0.05 (1ED95) mg/kg cisatracurium that was calculated based on actual body weight once when PTC \> 2.
GENETICobese patientsobese patients with elective laparoscopic colorectal surgery were selected,and the inclusion criteria were as follows: age 18-65, body mass index (BMI) 30-35, waist circumference (WC) : female ≥80cm, male ≥90cm, and American Society of Anesthesiologists (ASA) grade Ⅰ \~ Ⅲ.
GENETICnormal patientsnormal patients with elective laparoscopic colorectal surgery whose body mass index (BMI) 18-24 were selected,and American Society of Anesthesiologists (ASA) grade Ⅰ \~ Ⅲ.

Timeline

Start date
2021-03-16
Primary completion
2022-06-30
Completion
2022-07-03
First posted
2022-05-26
Last updated
2024-01-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05391958. Inclusion in this directory is not an endorsement.

Pharmacodynamics of Injection of Cisatracurium Base on Lean Body Mass Pattern to Maintain Deep Neuromuscular Blockade in (NCT05391958) · Clinical Trials Directory